Xanthomas and hyperlipidemias

https://doi.org/10.1016/S0190-9622(85)70139-9Get rights and content

The ability to recognize diverse clinical forms of xanthomas, such as tuberous, planar, eruptive and tendinous, is important in the detection of underlying systemic disease. A variety of primary genetic disorders, as well as numerous secondary conditions such as diabetes, obstructive liver disease, thyroid disease, renal disease, and pancreatitis, can lead to hyperlipoproteinemia that results in the formation not only of xanthomas but also of life-threatening vascular atherosclerosis. An understanding of the pathogenesis of the underlying lipoprotein alterations provides a rational approach to therapy utilizing dietary manipulations and drugs. Such treatment is capable of correcting most disorders of lipid metabolism, and, if appropriate therapy is initiated at the first sign of xanthoma evolution, it may prevent progression of atherosclerosis, provide resolution of xanthomas, and in some instances prevent serious pancreatitis.

References (155)

  • O Stein et al.

    Binding, internalization and degradation of low density lipoprotein by normal human fibroblasts and by fibroblasts from a case of homozygous familial hypercholesterolemia

    Proc Natl Acad Sci USA

    (1976)
  • MI New et al.

    The significance of blood lipid alteration in diabetes mellitus

    Diabetes

    (1963)
  • AL Warshaw et al.

    Inhibition of serum and urine amylase activity in pancreatitis and hyperlipemia

    Ann Surg

    (1975)
  • JB Marsh et al.

    Experimental reconstruction of metabolic pattern of lipid nephrosis: Key role of hepatic protein synthesis in hyperlipemia

    Metabolism

    (1960)
  • F Parker et al.

    Ultrastructural and lipid biochemical comparisons of human eruptive, tuberous and planar xanthomas

    Isr J Med Sci

    (1973)
  • F Parker

    Hyperlipoproteinemia and xanthomatosis

  • R Fleischmajer

    Cutaneous and tendon xanthomas

    Dermatologica

    (1964)
  • WR Harlan et al.

    Familial hypercholesterolemia: A genetic and metabolic study

    Medicine

    (1966)
  • A Gattereau et al.

    An improved radiological method for the evaluation of achilles tendon xanthomatosis

    Can Med Assoc J

    (1973)
  • AK Khachadurian

    Migratory polyarthritis in familial hypercholesterolemia (Type II hyperlipoproteinemia)

    Arthritis Rheum

    (1968)
  • CJ Glueck et al.

    Acute tendinitis and arthritis. A presenting symptom of familial Type II hyperlipoproteinemia

    JAMA

    (1968)
  • M Philippart et al.

    Cholestanolosis (cerebrotendinous xanthomatosis)

    Arch Neurol

    (1969)
  • V Shore et al.

    Abnormal high density lipoproteins in cerebrotendinous xanthomatosis

    J Clin Invest

    (1981)
  • AK Bbattacharyya et al.

    B-Sitosterolemia and xanthomatosis

    J Clin Invest

    (1974)
  • MD Polano

    Xanthomatosis and hyperlipoproteinemia

    Dermatologica

    (1974)
  • P Douste-Blazy et al.

    Increased frequency of Apo E-ND phenotype and hyperapobetalipoproteinemia in normolipidemic subjects and xan thelasmas of the eyelids

    Ann Intern Med

    (1982)
  • RH Rosenman et al.

    Relation of corneal arcus to cardiovascular risk factors and the incidence of coronary disease

    N Engl J Med

    (1924)
  • M Feiwel

    Xanthomatosis in cryoglobulinaemia and other paraproteinaemias with report of a case

    Br J Dermatol

    (1968)
  • WC Roberts

    Classification and etiology of hyperlipoproteinemia

    Fed Proc

    (1971)
  • JD Brunzel et al.

    Chylomicronemia syndrome. Symposium on lipid disorders

    Med Clin North Am

    (1983)
  • MA Mishkel et al.

    Xanthoma disseminatum

    Arch Dermatol

    (1977)
  • RJ Havel et al.

    Lipoproteins and lipid transport

  • JP Kane

    Plasma lipoproteins: Structure and metabolism

  • HB Brewer et al.

    Type III hyperlipoproteinemia: Diagnosis, molecular defects, pathology and treatment

    Ann Intern Med

    (1983)
  • EJ Blanchette-Mackie et al.

    Sites of lipoprotein lipase activity in adipose tissue perfused with chylomicrons: Electron microscope cytochemical study

    J Cell Biol

    (1971)
  • CH Hollenberg

    Effect of nutrition on activity and release of lipase from rat adipose tissue

    Am J Physiol

    (1959)
  • JC Kessler

    Effect of diabetes and insulin on the activity of myocardial and adipose tissue lipoprotein lipase of rats

    J Clin Invest

    (1963)
  • CJ Glueck et al.

    Estrogen-induced pancreatitis in patients with previously covert familial Type V hyperlipoproteinemia

    Metabolism

    (1972)
  • MS Brown et al.

    Receptor-mediated control of cholesterol metabolism. Study of human mutants has disclosed how cells regulate a substance that is both vital and lethal

    Science

    (1976)
  • JL Goldstein et al.

    The LDL receptor locus and the genetics of familial hypercholesterolemia

    Annu Rev Genet

    (1979)
  • MS Brown et al.

    Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic

    J Clin Invest

    (1983)
  • AK Bhattacharyya et al.

    Excretion of sterols from the skin of normal and hypercholesterolemic humans

    J Clin Invest

    (1972)
  • SM Grundy

    Treatment of hypercholesterolemia by interference with bile acid metabolism

    Arch Intern Med

    (1972)
  • JM Dietschy et al.

    Regulation of cholesterol metabolism

    N Engl J Med

    (1970)

    N Engl J Med

    (1970)

    N Engl J Med

    (1970)
  • HB Brewer et al.
  • JA Glomset

    The plasma lecithins: Cholesterol acyltransferase reaction

    J Lipid Res

    (1968)
  • MK Polano et al.

    Xanthomata in primary hyperlipoproteinemia

    Arch Dermatol

    (1969)
  • F Parker et al.

    Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: A correlative lipid, biochem ical, histochemical and electron microscopic study

    J Clin Invest

    (1970)
  • TF Whyne et al.

    Plasma apolipoprotein B and VLDL-, and LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography

    Atherosclerosis

    (1981)
  • JJ Maciejko et al.

    Apolipoprotein A-1 as a marker of angiographically assessed coronary artery disease

    N Engl J Med

    (1983)

    • Cited by (0)

    The CME articles are made possible through an educational grant from Syntex Laboratories, Inc.

    View full text
    Copyright © 1985 Published by Mosby, Inc.